Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Who May Benefit from BPC-157
PubChem Compound Summary for CID 9941957
Multidimensional investigation of potential anti-cancer targets of glutamine metabolism and their inhibitors Targeting glutamine metabolism-related enzymes and their inhibitors As indicated by the aforementioned evidence, it can be hypothesised that glutamine-addicted cancer cells are reliant on GLS for survival
Oral medications: slowed gastric emptying delays oral drug absorption
Endocrinologistsmedical doctors who specialize in this fieldare experts in treating diseases associated with hormonal systems, ranging from thyroid disease to diabetes mellitus
Dosage Determination
US$ 26.09
US$ 26.64
US$ 20.38
US$ 28.75
US$ 26.32
US$ 25.67
US$ 29.74
US$ 29.83
US$ 23.29
US$ 27.86
